| |
|
|
ALLSTON, MASS. - Cambridge-based Genzyme Corp. is adding two bioreactors to its $200-million, 180,000-sf Allston Landing facility. Expanding its biomanufacturing capacity, the plant will total six 2,000-liter bioreactors with the $30-million addition of the two new bioreactors, which should be operational by mid-2003.
|
|
 |
Would you like information like this delivered to your email inbox? Subscribe to Tradeline Updates to keep abreast of the latest conference developments, industry news, best practices and more! Sign Up Now!
|
|
Printer Friendly Version
Send to a Friend
